AQST
Aquestive Therapeutics IncNASDAQHEALTHCAREDRUG MANUFACTURERS - SPECIALTY & GENERIC
Key Statistics
Market Cap
$499.16M
P/E Ratio
—
EPS
$-0.78
Beta
1.53
52W High
$7.55
52W Low
$2.12
50-Day MA
$3.95
200-Day MA
$4.81
Dividend Yield
—
Profit Margin
-188.10%
Forward P/E
—
PEG Ratio
—
About Aquestive Therapeutics Inc
Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and marketing various products to address unmet medical needs in the United States and internationally. The company is headquartered in Warren, New Jersey.
Fundamentals
| Revenue (TTM) | $44.55M |
| Gross Profit (TTM) | $25.99M |
| EBITDA | $-70.48M |
| Operating Margin | -221.60% |
| Return on Equity | 0.00% |
| Return on Assets | -33.90% |
| Revenue/Share (TTM) | $0.42 |
| Book Value | $-0.28 |
| Price-to-Book | 14.15 |
| Price-to-Sales (TTM) | 11.21 |
| EV/Revenue | 9.56 |
| EV/EBITDA | -1.81 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 9.70% |
| Shares Outstanding | $122.05M |
| Float | $111.69M |
| % Insiders | 3.19% |
| % Institutions | 62.06% |
Analyst Ratings
Consensus ($8.89 target)
2
Strong Buy7
BuyData last updated: 4/7/2026